Pricing Log in Create free account

Clearmind Medicine Inc. (CMND) vs 60 Degrees Pharmaceuticals Inc. (SXTP)

Clearmind Medicine Inc. and 60 Degrees Pharmaceuticals Inc. are both Biotechnology companies. Clearmind Medicine Inc. and 60 Degrees Pharmaceuticals Inc. are of similar size ($3.3M and $3.2M). Clearmind Medicine Inc. has the higher net margin (0.00% vs −650.3%) and the higher return on invested capital (0.00% vs −348.6%). Across the 13 metrics below, Clearmind Medicine Inc. leads on 7 and 60 Degrees Pharmaceuticals Inc. on 6.

Valuation

Metric CMND SXTP Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.88 9.71
P/B 0.76 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.49 n/m 0.64
EV/Sales n/m 2.04 9.21
Earnings yield (1,476.45%) (252.37%) (33.15%)
Free cash flow yield (71.38%) (397.08%) (25.50%)

Profitability

Metric CMND SXTP Biotechnology median
Gross margin 0.00% 43.42% 65.16%
Operating margin 0.00% (691.33%) 0.00%
Net margin 0.00% (650.34%) 0.00%
Free cash flow margin 0.00% (745.93%) 0.00%
Return on equity (106.98%) 110.82% (56.36%)
Return on assets (71.81%) (186.70%) (48.04%)
Return on invested capital 0.00% (348.64%) 0.00%

Growth

Metric CMND SXTP Biotechnology median
Revenue growth (TTM) — 23.41% 6.02%
EPS growth (last fiscal year) 55.10% 84.19% 30.26%
Revenue growth, 5-year CAGR — (11.18%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMND SXTP Biotechnology median
Debt to equity 0.13 0.00 0.00
Current ratio 4.31 2.32 4.72
Net debt to EBITDA 0.68 0.37 0.96

Dividend

Metric CMND SXTP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CMND SXTP Biotechnology median
Market cap 3.26m 3.17m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack